|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 161 | 2018 | Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial | Janssens, Stefan P.; Bogaert, Jan; Zalewski, Jaroslaw; Toth, Attila; Adriaenssens, Tom; Belmans, Ann; Bennett, Johan; Claus, Piet; Desmet, Walter; Dubois, Christophe; Goetschalckx, Kaatje; Sinnaeve, Peter; Vandenberghe, Katleen; Vermeersch, Pieter; Lux, Arpad; Szelid, Zsolt; Durak, Monika; Lech, Piotr; Zmudka, Krzysztof; Pokreisz, Peter; VRANCKX, Pascal; Merkely, Bela; Bloch, Kenneth D.; Van de Werf, Frans | Journal Contribution | A1 |
| 162 | 2018 | Standardized End Point Definitions for Coronary Intervention Trials | Garcia-Garcia, Hector M.; McFadden, Eugene P.; Farb, Andrew; Mehran, Roxana; Stone, Gregg W.; Spertus, John; Onuma, Yoshinobu; Morel, Marie-angele; van Es, Gerrit-Anne; Zuckerman, Bram; Fearon, William F.; Taggart, David; Kappetein, Arie-Pieter; Krucoff, Mitchell W.; VRANCKX, Pascal; Windecker, Stephan; Cutlip, Donald; Serruys, Patrick W. | Journal Contribution | A1 |
| 163 | 2018 | High-Sensitive Cardiac Troponin Predicts 2-years Mortality in Patients with Coronary Artery Disease-subanalysis of the GLOBAL LEADERS trial | Chang, Chun Chin; Chichareon, Ply; Kogame, Norihiro; Modolo, Rodrigo; Takahashi, Kuniaki; Cequier, Angel; Carrie, Didier; Stables, Rod; Royaards, Kees-Jan; vom Dahl, Juergen; Onuma, Yoshinobu; Hamm, Christian; VRANCKX, Pascal; Valgimigli, Marco; Windecker, Stephan; Serruys, Patrick | Journal Contribution | M |
| 164 | 2018 | Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force | Ibanez, Borja; Halvorsen, Sigrun; Roffi, Marco; Bueno, Hector; Thiele, Holger; VRANCKX, Pascal; Neumann, Franz-Josef; Windecker, Stephan; James, Stefan | Journal Contribution | A2 |
| 165 | 2018 | The impact of bifurcation stenting techniques on the clinical events: the stratified analysis of 2,510 bifurcated lesions according to MADS classification in the Global LEADERS trial | Kogame, Norihiro; Asano, Taku; Chichareon, Ply; Modolo, Rodrigo; Takahashi, Kuniaki; Chang, Chun-Chin; Katagiri, Yuki; Janssens, Luc; Lemos, Pedro A.; Macaya, Carlos; Jasionowicz, Pawel; Kukreja, Neville; Abdellaoui, Mohamed; Onuma, Yoshinobu; VRANCKX, Pascal; Valgimigli, Marco; Windecker, Stephan; Serruys, Patrick | Journal Contribution | M |
| 166 | 2018 | Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial | VRANCKX, Pascal; Valgimigli, Marco; Juni, Peter; Hamm, Christian; Steg, Philippe Gabriel; Heg, Dik; van Es, Gerrit Anne; McFadden, Eugene P.; Onuma, Yoshinobu; van Meijeren, Cokky; Chichareon, Ply; BENIT, Edouard; Mollmann, Helge; Janssens, Luc; Ferrario, Maurizio; Moschovitis, Aris; Zurakowski, Aleksander; Dominici, Marcello; Van Geuns, Robert Jan; Huber, Kurt; Slagboom, Ton; Serruys, Patrick W.; Windecker, Stephan | Journal Contribution | A1 |
| 167 | 2018 | Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial | Valgimigli, Marco; Frigoli, Enrico; Leonardi, Sergio; VRANCKX, Pascal; Rothenbuhler, Martina; Tebaldi, Matteo; Varbella, Ferdinando; Calabro, Paolo; Garducci, Stefano; Rubartelli, Paolo; Briguori, Carlo; Ando, Giuseppe; Ferrario, Maurizio; Limbruno, Ugo; Garbo, Roberto; Sganzerla, Paolo; Russo, Filippo; Nazzaro, Marco; Lupi, Alessandro; Cortese, Bernardo; Ausiello, Arturo; Ierna, Salvatore; Esposito, Giovanni; Ferrante, Giuseppe; Santarelli, Andrea; Sardella, Gennaro; de Cesare, Nicoletta; Tosi, Paolo; van 't Hof, Arnoud; Omerovic, Elmir; Brugaletta, Salvatore; Windecker, Stephan; Heg, Dik; Juni, Peter | Journal Contribution | A1 |
| 168 | 2018 | Quality assessment in Belgian ST elevation myocardial infarction patients: results from the Belgian STEMI database | Claeys, Marc J.; Sinnaeve, Peter R.; Convens, Carl; Dubois, Philippe; Pourbaix, Suzanne; VRANCKX, Pascal; Gevaertg, Sofie; De Raedt, Herbert; Beauloye, Christophe; Argachai, Jean-Francois; Evrard, Patrick; Coussement, Patrick | Journal Contribution | A1 |
| 169 | 2017 | Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium | Seltzer, Jonathan H.; Heise, Ted; Carson, Peter; Canos, Daniel; Hiatt, Jo Carol; VRANCKX, Pascal; Christen, Thomas; Cutlip, Donald E. | Journal Contribution | A1 |
| 170 | 2017 | Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation | VRANCKX, Pascal; Frigoli, Enrico; Rothenbuhler, Martina; Tomassini, Francesco; Garducci, Stefano; Ando, Giuseppe; Picchi, Andrea; Sganzerla, Paolo; Paggi, Anita; Ugo, Fabrizio; Ausiello, Arturo; Sardella, Gennaro; Franco, Nicoletta; Nazzaro, Marco; de Cesare, Nicoletta; Tosi, Paolo; Falcone, Camillo; Vigna, Carlo; Mazzarotto, Pietro; Di Lorenzo, Emilio; Moretti, Claudio; Campo, Gianluca; Penzo, Carlo; Pasquetto, Giampaolo; Heg, Dik; Juni, Peter; Windecker, Stephan; Valgimigli, Marco | Journal Contribution | A1 |
| 171 | 2017 | Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study | Windecker, Stephan; Tijssen, Jan; Giustino, Gennaro; Guimaraes, Ana H. C.; Mehran, Roxana; Valgimigli, Marco; VRANCKX, Pascal; Welsh, Robert C.; Baber, Usman; van Es, Gerrit-Anne; Wildgoose, Peter; Volkl, Albert A.; Zazula, Ana; Thomitzek, Karen; Hemmrich, Melanie; Dangas, George D. | Journal Contribution | A1 |
| 172 | 2017 | Thrombo-embolic prevention after transcatheter aortic valve implantation | VRANCKX, Pascal; Windecker, Stephan; Welsh, Robert C.; Valgimigli, Marco; Mehran, Roxana; Dangas, George | Journal Contribution | A1 |
| 173 | 2017 | Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management AKI-MATRIX | Ando, Giuseppe; Cortese, Bernardo; Russo, Filippo; Rothenbhler, Martina; Frigoli, Enrico; Gargiulo, Giuseppe; Briguori, Carlo; VRANCKX, Pascal; Leonardi, Sergio; Guiducci, Vincenzo; Belloni, Flavia; Ferrari, Fabio; Hernandez, Jose Maria de la Torre; Curello, Salvatore; Liistro, Francesco; Perkan, Andrea; De Servi, Stefano; Casu, Gavino; Dellavalle, Antonio; Fischetti, Dionigi; Micari, Antonio; Loi, Bruno; Mangiacapra, Fabio; Russo, Nunzio; Tarantino, Fabio; Saia, Francesco; Heg, Dik; Windecker, Stephan; Juni, Peter; Valgimigli, Marco | Journal Contribution | A1 |
| 174 | 2016 | Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting scent implantation: rationale and design of the GLOBAL LEADERS trial | VRANCKX, Pascal; Valgimigli, Marco; Windecker, Stephan; Steg, Philippe Gabriel; Hamm, Christian; Juni, Peter; Garcia-Garcia, Hector M.; van Es, Gerrit Anne; Serruys, Patrick W. | Journal Contribution | A1 |
| 175 | 2016 | Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration | Costa, Francesco; Adamo, Marianna; Ariotti, Sara; Ferrante, Giuseppe; Navarese, Eliano Pio; Leonardi, Sergio; Garcia-Garcia, Hector; VRANCKX, Pascal; Valgimigli, Marco | Journal Contribution | A1 |
| 176 | 2016 | Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial | Gargiulo, Giuseppe; Costa, Francesco; Ariotti, Sara; Biscaglia, Simone; Campo, Gianluca; Esposito, Giovanni; Leonardi, Sergio; VRANCKX, Pascal; Windecker, Stephan; Valgimigli, Marco | Journal Contribution | A1 |
| 177 | 2016 | Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction | Pilgrim, Thomas; VRANCKX, Pascal; Valgimigli, Marco; Stefanini, Giulio G.; Piccolo, Raffaele; Rat, Julie; Rothenbuehler, Martina; Stortecky, Stefan; Raeber, Lorenz; Bloechlinger, Stefan; Hunziker, Lukas; Silber, Sigmund; Jueni, Peter; Serruys, Patrick W.; Windecker, Stephan | Journal Contribution | A1 |
| 178 | 2016 | A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More? | Gargiulo, Giuseppe; Windecker, Stephan; VRANCKX, Pascal; Gibson, Charles Michael; Mehran, Roxana; Valgimigli, Marco | Journal Contribution | A1 |
| 179 | 2016 | Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes The TRACER Trial | VRANCKX, Pascal; White, Harvey D.; Huang, Zhen; Mahaffey, Kenneth W.; Armstrong, Paul W.; Van de Werf, Frans; Moliterno, David J.; Wallentin, Lars; Held, Claes; Aylward, Philip E.; Cornel, Jan H.; Bode, Christoph; Huber, Kurt; Nicolau, Jose C.; Ruzyllo, Witold; Harrington, Robert A.; Tricoci, Pierluigi | Journal Contribution | A1 |
| 180 | 2016 | Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? | Ariotti, Sara; Adamo, Marianna; Costa, Francesco; Patialiakas, Athanasios; Briguori, Carlo; Thury, Attila; Colangelo, Salvatore; Campo, Gianluca; Tebaldi, Matteo; Ungi, Imre; Tondi, Stefano; Roffi, Marco; Menozzi, Alberto; de Cesare, Nicoletta; Garbo, Roberto; Meliga, Emanuele; Testa, Luca; Gabriel, Henrique Mesquita; Ferlini, Marco; VRANCKX, Pascal; Valgimigli, Marco | Journal Contribution | A1 |
Loading...
5
0
5
0
false